PIK3CB and neoplasm: All these evidences show that altered PI3K/AKT/mTOR altered pathway may induce tumorigenesis, and treatments that focus on these mutations and dysfunctions are targets of further studies, moreover, association of drugs can interrupt tumor progression in more than one point and avoid resistance caused by pathway crosstalk.